- Filed
- May 16, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 8, 2025 | 68.69M sh |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $107.91M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $109.15M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $68.31M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $77.72M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $68.31M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $77.72M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $121.95M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $133.53M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $162.7M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $174.7M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 68.69M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $310 |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$3.52M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.06 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.06 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $690.82K |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$4.01M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.02M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | −$7.13K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $1.91M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.9M |